scout.yahoo.com
Yahoo Scout
Yahoo Scout
akebia therapeutics
Searching…
Web results
help.yahoo.com
Ad
seekingalpha.com
Akebia Therapeutics, Inc. - Latest Press Releases
Want To Stay Updated? Latest News To Give You The Tools To Invest Smarter. Give Yourself the Resources to Pull Ahead. Try Premium for Just $4.95 For Your First Month
akebia.com
Home - Akebia Therapeutics
Akebia Therapeutics is a fully integrated biopharmaceutical company that develops and commercializes products for people with kidney disease. It has two FDA-approved products and a late stage product in global Phase 3...
finance.yahoo.com
Akebia Therapeutics, Inc. (AKBA) Stock Price, News, Quote ...
Find the latest Akebia Therapeutics, Inc. (AKBA) stock quote, history, news and other vital information to help you with your stock trading and investing.
www.marketwatch.com
AKBA Stock Price | Akebia Therapeutics Inc. Stock Quote (U.S ...
Mar 11, 2026 · AKBA | Complete Akebia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
www.barchart.com
Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 ...
Feb 26, 2026 · CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, tod...
www.google.com
Akebia Therapeutics Inc (AKBA) Stock Price & News - Google
Get the latest Akebia Therapeutics Inc (AKBA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
www.marketbeat.com
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Receives Average ...
1 day ago · Akebia Therapeutics, Inc, a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is focused on the development and commercialization of therapies for patients with kidney disease.
nationaltoday.com
Akebia Therapeutics Misses Q4 Earnings Estimates
Feb 26, 2026 · Akebia Therapeutics A clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for patients with kidney disease, headquartered in Cambridge, Massachusetts.